VJHemOnc is committed to improving our service to you

COMy 2019 | Relapsed myeloma treatment: what’s ahead?

VJHemOnc is committed to improving our service to you

Meral Beksac

Meral Beksac, MD, of Ankara University, Ankara, Turkey, discusses the options for treating relapsed multiple myeloma (MM), including second generation proteasome inhibitors, IMiDs and monoclonal antibodies. Furthermore, Dr Beskac talks about the exciting future of treatments using molecular and precision medicine by identifying genes involved in response to MM. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter